AIMC Topic: Drug Synergism

Clear Filters Showing 51 to 51 of 51 articles

Doxorubicin enhances (131)I-rituximab induced cell death in Raji cells.

Journal of cancer research and therapeutics Jan 1, 2015
AIM: There are various therapeutic modalities of treatment for non-Hodgkin's lymphoma, but with certain limitations, hence, investigating the scope of combined therapeutic approach.
Humans RNA, Messenger Cell Proliferation Signal Transduction Antineoplastic Combined Chemotherapy Protocols Apoptosis Blotting, Western Flow Cytometry Radiopharmaceuticals Doxorubicin Iodine Radioisotopes Drug Synergism Tumor Cells, Cultured Rituximab Poly(ADP-ribose) Polymerases Burkitt Lymphoma Radiation-Sensitizing Agents
View on PubMed DOI
Popular Topics
Recent Journals